Documents
- Press release - SynAct Pharma AB has successfully completed the bookbuilding procedure - directed issues provide the company with a total of up to 49.2 MSEK. March 27, 2024 - English
- Press release - SynAct Pharma AB announces intention to carry out directed share issues in total of approximately 48 MSEK March 26, 2024 - English